Sharechat Logo

Xero relocates technology officer to US beachhead

Tuesday 8th March 2011

Text too small?

Online accounting software company Xero is relocating its chief technology officer to the US to drive product development.

The company told an investor presentation today that it was establishing a beachhead in San Francisco where it will leverage off shareholder Peter Thiel.

Thiel, who co-founded PayPal and was an investor in Facebook, became an investor in Xero last year.

The investment in Xero was through Thiel's New Zealand investment firm Valar Ventures.

Xero has incorporated a US company called Xero Inc and is working on strategic partnerships in the US market. A full strategic update would be provided in late May, the company said.

Thiel has said that Xero's tight focus, robust product, and strong team should enable it to expand tremendously in the US.

"Millions of small and medium-sized businesses need an online accounting solution, especially in this time of increasing regulatory and tax complexity."

 

NZPA



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto
19th October 2021 Morning Report
PGG Wrightson Limited (NZX: PGW) Guidance Update
Vital Limited (NZX: VTL) Provides Update on PSN LMR
18th October 2021 Morning Report
T&G Global Limited (NZX: TGG) FY21 Earnings Guidance Update
Arvida Group Limited (NZX: ARV) Successful Completion of $155m Placement
FreshLeaf: Cannabis on course to be 'medicine of the masses'